Reference, study duration | Outcome measures | Results (95% Confidence interval) |
---|---|---|
Moore et al. 2010 [19] 12 months | NA |  |
Ettner et al. 2014 [20] 12 months | -Alcohol discussion with PC physician, % | I = 23% vs C = 13%** |
Wallhed-Finn et al. 2018 [21] 6 months | -Number of visits, mean | I = 2.9 vs C = 4.7*** |
-Duration of treatment, min | I = 74 vs C = 187*** | |
-AUD pharmacotherapy, % | NS | |
Drummond et al. 2009 [22] 6 months | NA |  |
Coulton et al. 2017 [23] 12 months | NA |  |
Oslin et al. 2013 [24] 6.5 months | -Mean number of visits (SD) | NS |
-Proportion of patients with at least two addiction treatment visits | OR 6.97 (4.04, 12.05)*** | |
-Patients treated with naltrexone, % | I = 65.9 vs C = 11.5*** | |
Watkins et al. 2017 [25] SUMMIT trial (Data of AUD subgroup without comorbid opioid dependence) 6 months | -Patients received any evidence-based treatment, % | I = 39.4 vs C = 15.2; OR 5.09 (2.33–11.14)*** |
-Patients received any brief treatment, % | I = 37.5 vs C = 10.10; OR 7.70 (3.33–18.32)*** | |
-Patients received any medication assisted treatment, % | NS | |
-HEDIS initiation, % | I = 32.69 vs C = 9.09; OR 6.16 (2.56–14.85)*** | |
-HEDIS engagement, % | I = 14.42 vs C = 4.04; OR 6.56 (1.78–24.15)* | |
Upshur et al. 2015 [26] Project RENEWAL 6 months | -Number of visits, mean (6 mo) | I = 12.1 vs C = 6.2** |
-Meet criteria for spending time in drug/alcohol treatment, % (3 &6 mo) | NS, NS | |
-Talking about substance abuse with counsellor, % (3 & 6 mo) | 3 mo: I = 67.6 vs C = 30.6** 6 mo: NS | |
-Attending AA meetings, % (3 & 6 mo) | NS, NS | |
-Patients visiting mental health provider, %, (3 & 6 mo) | NS, NS | |
-Total contacts with any substance use service, % (3 & 6 mo) | 3 mo: I = 75.7 vs C = 44.4* 6 mo: I = 75 vs C = 47.2** | |
Bradley et al. 2018 [27] CHOICE trial 12 months | -AUD medication use, % (3&12 mo) | 3 mo: I = 14 vs C = 4.6** 12 mo: I = 32 vs C = 8.4*** |
-AUD medication use> 30 days, %, (3 &12 mo) | 3 mo: I = 9.3 vs C = 2.6** 12 mo: I = 26.0 vs C = 7.1*** | |
-VA addictions treatment, %, (3&12 mo) | NS, NS | |
-AA involvement, % (12 mo) | NS | |
-Any alcohol-related care, % (3&12 mo) | 3 mo: I = 18 vs C = 8.4** 12 mo: I = 42.0 vs C = 26.0** | |
Saitz et al. 2013 [28] AHEAD trial (Data of AUD subgroup with/ without SUD) 12 months | -Any mutual help meeting attendance, % | NS |
-Any addiction treatment, % | I = 43 vs C = 42; OR 1.36 (1.01–1.84)* | |
-Any inpatient addiction treatment, % | NS | |
-Any addiction medication, % | I = 16 vs C = 10; OR 2.12 (1.29–3.48)** | |
Willenbring et al. 1999 [29] 24 months | -VA hospital days over prior 2 year, psychiatric and alcohol treatment, mean | NS |
-VA clinic visits over prior 2 years | I = 42.2 vs C = 17.4** |